Stat6 activation and Th2 cell proliferation driven by CD28 signals

European Journal of Immunology

Volumn 30, Issue 5, 2000, Pages 1416-1424

  Oki, Shinji ^a,b   Otsuki, Noriko ^a   Kohsaka, Takao ^a   Azuma, Miyuki ^a  

^a NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^b The New York Presbyterian Hospital   (United States)

Author keywords

CD28; IL 4 production; Phosphorylation; Stat6; T cell differentiation

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CD3 ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MONOCLONAL ANTIBODY; STAT6 PROTEIN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TH2 CELL; TRANSACTIVATION;

EID: 0034122856     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(200005)30:5<1416::AID-IMMU1416>3.0.CO;2-M     Document Type: Article

References (55)

1. June, C. H., Bluestone, J. A., Nadler, L. M. and Thompson, C. B., The B7 and CD28 receptor families. Immunol. Today 1994. 15: 321-331.
2. Allison, J. P., CD28-B7 interactions in T-cell activation. Curr. Opin. Immunol. 1994. 6: 414-419.
3. June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T. and Thompson, C. B., T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol. Cell. Biol. 1987. 7: 4472-4481.
4. Azuma, M., Cayabyab, M., Buck, D., Phillips, J. H. and Lanier, L. L., CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes. J. Exp. Med. 1992. 175: 353-360.
5. Kuchroo, V. K., Das, M. P., Brown, J. A., Ranger, A. M., Zamvil, S. S., Sobel, R. A., Weiner, H. L., Nabavi, N. and Glimcher, L. H., B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 1995. 80: 707-718.
6. + 45RO T cells by anti-CD28 plus IL-2: Induction of clonal expansion and priming for a Th2 phenotype. J. Immunol. 1996. 156: 4100-4106.
7. Gause, W. C., Chen, S. J., Greenwald, R. J., Halvorson, M. J., Lu, P., Zhou, X. D., Morris, S. C., Lee, K. P., June, C. H., Finkelman, F. D., Urban, J. F. and Abe, R., CD28 dependence of T cell differentiation to IL-4 production varies with the particular type 2 immune response. J. Immunol. 1997. 158: 4082-4087.
8. Nakajima, A., Watanabe, N., Yoshino, S., Yagita, H., Okumura, K. and Azuma, M., Requirement of CD28-CD86 co-stimulation in the interaction between antigen-primed T helper type 2 and B cells. Int. Immunol. 1997. 9: 637-644.
9. Rulifson, I. C., Sperling, A. I., Fields, P. E., Fitch, F. W. and Bluestone, J. A., CD28 costimulation promotes the production of Th2 cytokines. J. Immunol. 1997. 158: 658-665.
10. Corry, D. B., Reiner, S. L., Linsley, P. S. and Locksley, R. M., Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 1994. 153: 4142-4148.
11. Lenschow, D. J., Ho, S. C., Sattar, H., Rhee, L., Gray, G., Nabavi, N., Herold, K. C. and Bluestone, J. A., Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J. Exp. Med. 1995. 181: 1145-1155.
12. Sayegh, M. H., Akalin, E., Hancock, W. W., Russell, M. E., Carpenter, C. B., Linsley, P. S. and Turka, L. A., CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J. Exp. Med. 1995. 181: 1869-1874.
13. Lenschow, D. J., Herold, K. C., Rhee, L., Patel, B., Koons, A., Qin, H. Y., Fuchs, E., Singh, B., Thompson, C. B. and Bluestone, J. A., CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity 1996. 5: 285-293.
14. Schweitzer, A. N. and Sharpe, A. H., Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. J. Immunol. 1998. 161: 2762-2771.
15. Khattri, R., Auger, J. A., Griffin, M. D., Sharpe, A. H. and Bluestone, J. A., Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J. Immunol. 1999. 162: 5784-5791.
16. Coffman, R. L. and von der Weid, T., Multiple pathways for the initiation of T helper 2 (Th2) responses. J. Exp. Med. 1997. 185: 373-375.
17. Yoshimoto, T. and Paul, W. E., CD4pos, NK1.1pos T cells promptly produce interleukin-4 in response to in vivo challenge with anti-CD3. J. Exp. Med. 1994. 179: 1285-1295.
18. Kamogawa, Y., Minasi, L. A., Carding, S. R., Bottomly, K. and Flavell, R. A., The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 1993. 75: 985-995.
19. Rocken, M., Saurat, J. H. and Hauser, C., A common precursor for CD4+ T cells producing IL-2 or IL-4. J. Immunol. 1992. 148: 1031-1036.
20. Ferrick, D. A., Schrenzel, M. D., Mulvania, T., Hsieh, B., Ferlin, W. G. and Lepper, H., Differential production of interferon-gamma and interleukin-4 in response to TM- and Th2-stimulating pathogens by gamma delta T cells in vivo. Nature 1995. 373: 255-257.
21. Plaut, M., Pierce, J. H., Watson, C. J., Hanley, H. J., Nordan, R. P. and Paul, W. E., Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon Rl or to calcium ionophores. Nature 1989. 339: 64-67.
22. Brunner, T., Heusser, C. H. and Dahinden, C. A., Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 1993. 177: 605-611.
23. Yin, T., Tsang, M. L. and Yang, Y. C., JAK1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J. Biol. Chem. 1994. 269: 26614-26617.
24. Malabarba, M. G., Kirken, R. A., Rui, H., Koettnitz, K., Kawamura, M., O'Shea, J. J., Kalthoff, F. S. and Farrar, W. L., Activation of JAK3. but not JAK1, is critical to interleukin-4 (IL-4) stimulated proliferation and requires a membrane-proximal region of IL-4 receptor alpha. J. Biol. Chem. 1995. 270: 9630-9637.
25. Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasseur, M. and McKnight, S. L., An interleukin-4-induced transcription factor: IL-4 Stat. Science 1994. 265: 1701-1706.
26. Quelle, F. W., Shimoda, K., Thierfelder, W. et al., Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol. Cell. Biol. 1995. 15: 3336-3343.
27. Kaplan, M. H., Schindler, U., Smiley, S. T. and Grusby, M. J., Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996. 4: 313-319.
28. Shimoda, K., van Deursen, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A., Doherty, P. C., Grosveld, G., Paul, W. E. and Ihle, J. N., Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996. 380: 630-633.
29. Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S., Nakanishi, K., Yoshida, N., Kishimoto, T. and Akira, S., Essential role of Stat6 in IL-4 signalling. Nature 1996. 380: 627-630.
30. Noben-Trauth, N., Schultz, L. D., Brombacher, F., Urban, J., Jr., Gu, H. and Paul, W. E., An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 1997. 94: 10838-10843.
31. Moriggl, R., Kristofic, C., Kinzel, B., Volarevic, S., Groner, B. and Brinkmann, V., Activation of STAT proteins and cytokine genes in human Th1 and Th2 cells generated in the absence of IL-12 and IL-4. J. Immunol. 1998. 160: 3385-3392.
32. Davydov, I. V., Krammer, P. H. and Li, W. M., Nuclear factor-IL6 activates the human IL-4 promoter in T cells. J. Immunol. 1995. 155: 5273-5279.
33. Rincon, M., Anguita, J., Nakamura, T., Fikrig, E. and Flavell, R. A., Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J. Exp. Med. 1997. 185: 461-469.
34. Flynn, S., Toellner, K. M., Raykundalia, C., Goodall, M. and Lane, P., CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J. Exp. Med. 1998. 188: 297-304.
35. Hanissian, S. H. and Geha, R. S., Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 1997. 6: 379-387.
36. Callard, R. E., Matthews, D. J. and Hibbert, L., IL-4 and IL-13 receptors: are they one and the same? Immunol. Today 1996. 17: 108-110.
37. Curiel, R. E., Lahesmaa, R., Subleski, J., Cippitelli, M., Kirken, R. A., Young, H. A. and Ghosh, P., Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene. Eur. J. Immunol. 1997. 27: 1982-1987.
38. Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A. and Sinigaglia, F., Differential expression of che mokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 1998. 187: 129-134.
39. Truitt, K. E., Hicks, C. M. and lmboden, J. B., Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J. Exp. Med. 1994. 179: 1071-1076.
40. Schneider, H., Prasad, K. V., Shoelson, S. E. and Rudd, C. E., CTLA-4 binding to the lipid kinase phosphatidylinositol 3-kinase in T cells. J. Exp. Med. 1995. 181: 351-355.
41. Schneider, H., Cai, Y. C., Prasad, K. V., Shoelson, S. E. and Rudd, C. E., T cell antigen CD28 binds to the GRB-2/SOS complex, regulators of p21 ras. Eur. J. Immunol. 1995. 25: 1044-1050.
42. Schwartz, R. H., A cell culture model for T lymphocyte clonal anergy, Science 1990. 248: 1394-1356.
43. Nishina, H., Bachmann, M., Oliveira-dos-Santos, A. J., Kozieradzki, l., Fischer, K. D., Odermatt, B., Wakeham, A., Shahinian, A., Takimoto, H., Bernstein, A., Mak, T. W., Woodgett, J. R., Ohashi, P. S. and Penninger, J. M., Impaired CD28-mediated interleukin 2 production and proliferation in stress kinase SAPK/ ERK1 kinase (SEK1)/mitogen-activated protein kinase kinase 4 (MKK4)-deficient T lymphocytes. J. Exp. Med. 1997. 186: 941-953.
44. Raab, M., Cai, Y. C., Bunnell, S. C., Heyeck, S. D., Berg, L. J. and Rudd, C. E., p56Lck and p59Fyn regulate CD28 binding to phosphatidylinositol 3-kinase, growth factor receptor-bound protein GRB-2, and T cell-specific protein-tyrosine kinase ITK: implications for T-cell costimulation. Proc. Natl. Acad. Sci. USA 1995. 92: 8891-8895.
45. Chuang, E., Lee, K. M., Bobbins, M. D., Duerr, J. M., Alegre, M. L., Hambor, J. E., Neveu, M. J., Bluestone, J. A. and Thompson, C. B., Regulation of cytotoxic T lymphocyte-associated molecule-4 by Src kinases. J. Immunol. 1999. 162: 1270-1277.
46. Yamashita, M., Hashimoto, K., Kimura, M., Kubo, M., Tada, T. and Nakayama, T., Requirement for p56(lck) tyrosine kinase activation in Th subset differentiation. Int. Immunol. 1998. 10: 577-591.
47. Agarwal, S. and Rao, A., Modulation of chromatin structure regulates cytokine gene expressing during T cell differentiation. Immunity 1998. 9: 765-775.
48. Kurata, H., Lee, H. J., O'Garra, A. and Arai, N., Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 1999. 11: 677-688.
49. Rodríguez-Palmero, M., Hara, T., Thumbs, A. and Hünig, T., Triggering of T cell proliferation through CD28 induces GATA-3 and promotes T helper type 2 differentiation in vitro and in vivo. Eur. J. Immunol. 1999. 29: 3914-3924.
50. Yoshida, H., Nishina, H., Takimoto, H., Marengere, L. E. M., Wakeham, A. C., Bouchard, D., Kong, Y.-Y., Ohteki, T., Shahinian, A., Bachmann, M., Ohashi, P. S., Penninger, J. M., Crabtree, G. R. and Mak, T. W., The transcriptional factor NF-ATd regulates lymphocyte proliferation and Th2 cytokine production. Immunity 1998. 8: 115-124.
51. Hosken, N. A., Shibuya, K., Heath, A. W., Murphy, K. M. and O'Garra, A., The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha betatransgenic model. J. Exp. Med. 1995. 182: 1579-1584.
52. Guery, J. C., Galbiati, F., Smiroldo, S. and Adorini, L., Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)- microglobulin-deficient BALB/c mice. J. Exp. Med. 1996. 183: 485-497.
53. Tao, X., Constant, S., Jorritsma, P. and Bottomly, K., Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation. J. Immunol. 1997. 159: 5956-5963.
54. Lanier, L. L., O'Fallon, S., Somoza, C., Phillips, J. H., Linsley, P. S., Okumura, K., Ito, D. and Azuma, M., CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J. Immunol. 1995. 154: 97-105.
55. Oki, S., Kohsaka, T. and Azuma, M., Augmentation of CTLA-4 expression by wortmannin. Involvement of lysosomal sorting properties of CTLA-4. Int. Immunol. 1999. 11: 1563-1571.